Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Littlewood

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Paediatric Respiratory Reviews|November 25, 2003
Newborn screening programmes for cystic fibrosisKevin W Southern, James M Littlewood
Pediatric Pulmonology|November 17, 2005
Diagnosis and treatment of intestinal malabsorption in cystic fibrosisJames M Littlewood, Susan P Wolfe, Steven P Conway
Expert Opinion on Drug Safety|February 24, 2011
A 2-year post-authorization safety study of high-strength pancreatic enzyme replacement therapy (pancreatin 40,000) in cystic fibrosisJames M Littlewood, Gary J Connett, Suntje Sander-Struckmeier, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 7, 2004
Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patientsTim W R Lee, Keith G Brownlee, Steven P Conway, et al.
Pediatric Pulmonology|January 20, 2004
Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis centerTim W R Lee, Keith G Brownlee, Miles Denton, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Paediatric Respiratory Reviews|November 25, 2003
Newborn screening programmes for cystic fibrosisKevin W Southern, James M Littlewood
Pediatric Pulmonology|November 17, 2005
Diagnosis and treatment of intestinal malabsorption in cystic fibrosisJames M Littlewood, Susan P Wolfe, Steven P Conway
Expert Opinion on Drug Safety|February 24, 2011
A 2-year post-authorization safety study of high-strength pancreatic enzyme replacement therapy (pancreatin 40,000) in cystic fibrosisJames M Littlewood, Gary J Connett, Suntje Sander-Struckmeier, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 7, 2004
Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patientsTim W R Lee, Keith G Brownlee, Steven P Conway, et al.
Pediatric Pulmonology|January 20, 2004
Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis centerTim W R Lee, Keith G Brownlee, Miles Denton, et al.
Pageof 1